Key Highlights
- Shares of Aehr Test Systems soared more than 13% Thursday following news of another production equipment order for its FOX-XP wafer-level burn-in platform.
- The company has now secured three FOX-XP orders in 2026, including a $14 million contract in February and an additional order in March.
- The latest order originated from Aehr’s primary silicon photonics client, which has already deployed and operationalized its initial system.
- The FOX-XP platform enables simultaneous testing of up to nine 300mm wafers with complete automation and zero manual intervention.
- With fiscal Q4 and full-year 2026 results scheduled for July 14, the order timing adds positive momentum before the earnings announcement.
Shares of Aehr Test Systems (AEHR) rallied over 13% during Thursday’s trading session following the company’s disclosure of a new equipment order from its primary silicon photonics partner. By midday, the stock was holding gains of approximately 11.75%.
The contract involves a fully automated FOX-XP wafer-level burn-in (WLBI) platform, combined with the FOX WaferPak AutoAligner technology. This integrated solution enables simultaneous testing of nine 300mm wafers without requiring any manual intervention.
The client plans to deploy this equipment for mass production of silicon photonics components designed for AI optical interconnects and large-scale data center applications.
This represents a repeat purchase from an existing customer. The same client previously received its inaugural FOX-XP production unit during fiscal year 2026, and Aehr has verified that the system has been successfully integrated and is currently operational.
Chief Executive Officer Gayn Erickson characterized the development as “another important milestone” in the ongoing partnership with this customer, expressing satisfaction at “receiving this additional follow-on production order early in our new fiscal year.”
The order also represents Aehr’s third FOX-XP WLBI contract secured in 2026. The initial order arrived in February with a value of $14 million, with a subsequent order following in March.
Order Volume Exceeds Company Projections
Back in April, Aehr disclosed that it had secured over $92 million in orders throughout the latter half of fiscal 2026. This figure substantially exceeded the company’s previous guidance range of $60 million to $80 million.
Analyst consensus tracked by Fiscal.ai projects Aehr’s yearly revenue will expand from $49.8 million in 2026 to $85.1 million in 2027.
Broader market performance remained subdued on Thursday. The Nasdaq climbed 0.4% while the S&P 500 advanced 0.2%. Industry competitors including Teradyne and FormFactor released no significant announcements, indicating that AEHR’s price movement was exclusively attributable to its order news.
Fiscal Year Results Approaching
The announcement’s timing carries additional significance. Aehr is set to publish its fiscal 2026 fourth-quarter and complete-year financial results on July 14 — merely five days from Thursday’s order disclosure.
This close timing likely encouraged investors to act swiftly. A verified production order from a strategic customer, delivered just ahead of earnings, represents a constructive indicator entering the financial report.
Aehr specializes in testing and burn-in equipment for semiconductor applications spanning power semiconductors, sensor devices, memory components, processing units, and silicon photonics products. The FOX-XP system has served as the company’s primary growth catalyst amid the ongoing AI infrastructure expansion.
According to the company, its customer is advancing technology designed to enhance data transmission rates while reducing power consumption in artificial intelligence processors and high-performance computing architectures.
As of Thursday morning, AEHR shares had posted gains exceeding 13%, propelled by the third FOX-XP order announcement of 2026 and anticipation surrounding the fiscal year earnings release scheduled for July 14.





